% | $
Quotes you view appear here for quick access.

Genomic Health Inc. Message Board

  • terry_amln terry_amln Aug 16, 2012 12:56 AM Flag

    Now I'm worried ... - )

    Jim Cramer, the class clowns "The Street" has "upgraded" GHDX.The last line in the rating is the hook.
    Good Luck

    NEW YORK (TheStreet) -- Genomic Health (Nasdaq:GHDX) has been upgraded by TheStreet Ratings from hold to buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
27.82-0.38(-1.35%)Jul 25 4:00 PMEDT